Disclosed are syntheses suitable for large scale manufacture of novel compounds that are partial and full A.sub.1 adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.

 
Web www.patentalert.com

< Tyrosinase activity cntrolling agent, process for producing the same and external preparations containing the same

< Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer

> 2-Substituted-6-trifluoromethyl purine derivatives with adenosine-A3 antagonistic activity

> N-pyrazole A2A receptor agonists
~ 00244